DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
O’Connor CM, Gattis WA, Uretsky BF, Adams KF jr, McNulty SE, Grossman SH. et al.
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
Am Heart J 1999; 138: 78-86
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.